Gossamer Bio (GOSS) Cash & Equivalents: 2022-2025
Historic Cash & Equivalents for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $8.9 million.
- Gossamer Bio's Cash & Equivalents fell 68.62% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year decrease of 68.62%. This contributed to the annual value of $46.1 million for FY2024, which is 43.49% up from last year.
- Gossamer Bio's Cash & Equivalents amounted to $8.9 million in Q3 2025, which was down 66.05% from $26.3 million recorded in Q2 2025.
- Gossamer Bio's 5-year Cash & Equivalents high stood at $153.5 million for Q3 2022, and its period low was $8.9 million during Q3 2025.
- Over the past 3 years, Gossamer Bio's median Cash & Equivalents value was $37.0 million (recorded in 2023), while the average stood at $43.8 million.
- Per our database at Business Quant, Gossamer Bio's Cash & Equivalents plummeted by 71.32% in 2023 and then spiked by 134.78% in 2024.
- Over the past 4 years, Gossamer Bio's Cash & Equivalents (Quarterly) stood at $112.0 million in 2022, then tumbled by 71.32% to $32.1 million in 2023, then surged by 43.49% to $46.1 million in 2024, then tumbled by 68.62% to $8.9 million in 2025.
- Its last three reported values are $8.9 million in Q3 2025, $26.3 million for Q2 2025, and $29.0 million during Q1 2025.